Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CAMARA: Ferinject for Iron Deficiency in Cancer
NCT03625661Completed
- Sponsor
- Institut Cancérologique de l'Ouest
- Start
- Feb 2014
- Primary completion
- Jun 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of ferric carboxymaltose in iron deficiency anemia (IDA), sponsored by Institut Cancérologique de l'Ouest. Primary endpoint: Evaluation of the quality of life of patients at 6 months. Started Feb 2014; status: completed.
02
Drugs
ferric carboxymaltose
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on NCT03625661.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03625661.